Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Control. 2012 Apr;19(2 Suppl):3-9.

Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.

Author information

1
Northern Michigan University School of Nursing, Marquette, Michigan 49855, USA. rita_wickham@yahoo.com

Abstract

BACKGROUND:

Chemotherapy-induced nausea and vomiting (CINV) is one of the most debilitating toxicities associated with cancer treatment. Although effective antiemetic agents are available, their use in practice often is suboptimal.

METHODS:

The author reviews the pathophysiology of CINV as well as the drug classes and cost considerations that should be incorporated into treatment planning.

RESULTS:

Several drug classes, including 5-hydroxytryptamine-3 receptor antagonists, neurokinin-1 receptor antagonists, and corticosteroids, are effective, especially when used in combination. Older antiemetic agents, such as prochlorperazine and metoclopramide, as well as olanzapine may provide reasonable alternatives in certain settings.

CONCLUSIONS:

Interventions for CINV should include standard-of-care antiemetics combined with corticosteroids. The cost of using older, less expensive antiemetics may be outweighed by the expenditures to rescue patients after suboptimal prophylaxis, as well as the indirect costs of missed work and lost productivity.

PMID:
22488022
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for H. Lee Moffitt Cancer Center and Research Institute
    Loading ...
    Support Center